| RS1567556386 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567556454 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Li-Fraumeni syndrome |
| RS1567556576 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567556618 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567556752 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neoplasm |
| RS1567556784 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1567556914 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Ovarian neoplasm |
| RS1567556930 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Neoplasm |
| RS1567556956 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome 1, Li-Fraumeni syndrome |
| RS1567557016 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567557177 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567557258 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Li-Fraumeni syndrome 1 |
| RS1567557697 |
MYH3
|
Health Risk |
Likely pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS1567558112 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1567558314 |
MYH3
|
Health Risk |
Pathogenic |
Contractures, pterygia |
| RS1567559027 |
MYH3
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS1567559562 |
MYH3
|
Health Risk |
Likely pathogenic |
Contractures, pterygia |
| RS1567559851 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS1567560080 |
MYH3
|
Health Risk |
Likely pathogenic |
Contractures, pterygia |
| RS1567560601 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567560718 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1567561137 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS1567561598 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567563311 |
ACADVL
|
Health Risk |
Likely pathogenic |
— |
| RS1567564042 |
MYH3
|
Health Risk |
Pathogenic |
Contractures, pterygia |
| RS1567564499 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567565643 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567565733 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567566026 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567566228 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567567249 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1567567440 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, ACADVL-related disorder |
| RS1567568217 |
NUP88
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 4, Fetal akinesia deformation sequence 4 |
| RS1567569262 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1567571065 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571075 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571141 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571184 |
FOXC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Distichiasis-lymphedema syndrome, Inborn genetic diseases |
| RS1567571276 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571345 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571360 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571564 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Non-immune hydrops fetalis |
| RS1567571636 |
FOXC2
|
Health Risk |
Pathogenic |
LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS, LYMPHEDEMA-DISTICHIASIS SYNDROME WITH RENAL DISEASE AND DIABETES MELLITUS |
| RS1567571702 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571823 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571863 |
FOXC2
|
Health Risk |
Pathogenic |
Distichiasis-lymphedema syndrome, Distichiasis-lymphedema syndrome |
| RS1567571990 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567572265 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567573538 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1567574291 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567574466 |
ANKRD11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1567575193 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 2, Retinitis pigmentosa 74 |
| RS1567576202 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1567578243 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS1567579092 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567579525 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567583835 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567584842 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome |
| RS1567591276 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1567592494 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1567592815 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567593047 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1567598479 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1567598488 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567599296 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1567599993 |
CTC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 1, Dyskeratosis congenita |
| RS1567601223 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1567601355 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1567601557 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Neurodevelopmental abnormality |
| RS1567603987 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Inborn genetic diseases |
| RS1567604012 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS1567604571 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1567607328 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS1567607653 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1567607736 |
CYBA
|
Health Risk |
Pathogenic |
— |
| RS1567608510 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 |
| RS1567608718 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1567608830 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1567608853 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1567608876 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS1567609067 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS1567609091 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1567609103 |
CTC1
|
Health Risk |
Pathogenic |
— |
| RS1567609845 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1567610917 |
CTCF
|
Health Risk |
Conflicting classifications of pathogenicity |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS1567611231 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567611281 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567611351 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567611375 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567611380 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567611457 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567611496 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1567611587 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567611604 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567612415 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567612435 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567612483 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567612488 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567612531 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567612641 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |